| Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression N Galldiks, M Kocher, G Ceccon, JM Werner, A Brunn, M Deckert, ... Neuro-oncology 22 (1), 17-30, 2020 | 137 | 2020 |
| FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma P Lohmann, P Stavrinou, K Lipke, EK Bauer, G Ceccon, JM Werner, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-12, 2018 | 105 | 2018 |
| FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... Cancers 12 (12), 3835, 2020 | 87 | 2020 |
| Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients P Lohmann, JM Werner, NJ Shah, GR Fink, KJ Langen, N Galldiks Cancers 11 (2), 153, 2019 | 70 | 2019 |
| Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI JM Werner, G Stoffels, T Lichtenstein, J Borggrefe, P Lohmann, G Ceccon, ... European journal of nuclear medicine and molecular imaging 46, 1889-1901, 2019 | 66 | 2019 |
| Discordance and conversion rates of progesterone-, estrogen-, and HER2/neu-receptor status in primary breast cancer and brain metastasis mainly triggered by hormone therapy M Timmer, JM Werner, G Roehn, M Ortmann, T Blau, C Cramer, ... Anticancer research 37 (9), 4859-4865, 2017 | 48 | 2017 |
| Current landscape and emerging fields of PET imaging in patients with brain tumors JM Werner, P Lohmann, GR Fink, KJ Langen, N Galldiks Molecules 25 (6), 1471, 2020 | 43 | 2020 |
| Treatment monitoring of immunotherapy and targeted therapy using 18F-FET PET in patients with melanoma and lung cancer brain metastases: initial experiences N Galldiks, DSY Abdulla, M Scheffler, F Wolpert, JM Werner, M Hüllner, ... Journal of nuclear medicine 62 (4), 464-470, 2021 | 42 | 2021 |
| Dabrafenib treatment in a patient with an epithelioid glioblastoma and BRAF V600E mutation G Ceccon, JM Werner, V Dunkl, C Tscherpel, G Stoffels, A Brunn, ... International journal of molecular sciences 19 (4), 1090, 2018 | 41 | 2018 |
| Early treatment response assessment using 18F-FET PET compared with contrast-enhanced MRI in glioma patients after adjuvant temozolomide chemotherapy G Ceccon, P Lohmann, JM Werner, C Tscherpel, V Dunkl, G Stoffels, ... Journal of Nuclear Medicine 62 (7), 918-925, 2021 | 39 | 2021 |
| Diagnosis of pseudoprogression following lomustine–temozolomide chemoradiation in newly diagnosed glioblastoma patients using FET-PET JM Werner, J Weller, G Ceccon, C Schaub, C Tscherpel, P Lohmann, ... Clinical cancer research 27 (13), 3704-3713, 2021 | 32 | 2021 |
| Feature-based PET/MRI radiomics in patients with brain tumors P Lohmann, AK Meißner, M Kocher, EK Bauer, JM Werner, GR Fink, ... Neuro-oncology advances 2 (Supplement_4), iv15-iv21, 2020 | 28 | 2020 |
| Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET EK Bauer, G Stoffels, T Blau, G Reifenberger, J Felsberg, JM Werner, ... European journal of nuclear medicine and molecular imaging 47, 1486-1495, 2020 | 25 | 2020 |
| Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma JM Werner, V Schweinsberg, M Schroeter, B von Reutern, MP Malter, ... Frontiers in Oncology 9, 84, 2019 | 22 | 2019 |
| Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups M Trommer, A Adams, E Celik, J Fan, D Funken, JM Herter, P Linde, ... Cancers 14 (5), 1240, 2022 | 21 | 2022 |
| Use of advanced neuroimaging and artificial intelligence in meningiomas N Galldiks, F Angenstein, JM Werner, EK Bauer, R Gutsche, GR Fink, ... Brain pathology 32 (2), e13015, 2022 | 20 | 2022 |
| Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors N Galldiks, P Lohmann, JM Werner, G Ceccon, GR Fink, KJ Langen Expert review of anticancer therapy 20 (1), 9-15, 2020 | 16 | 2020 |
| Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI N Galldiks, JM Werner, C Tscherpel, GR Fink, KJ Langen Neuro-oncology advances 1 (1), vdz038, 2019 | 16 | 2019 |
| Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas MM Wollring, JM Werner, G Ceccon, P Lohmann, CP Filss, GR Fink, ... Journal of Neuro-oncology 162 (3), 481-488, 2023 | 15 | 2023 |
| Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience A Heinzel, D Dedic, N Galldiks, P Lohmann, G Stoffels, CP Filss, ... Cancers 14 (14), 3336, 2022 | 15 | 2022 |
Norbert GalldiksProfessor of Neurology, University Hospital Cologne & Research Center Juelich (INM-3)Верификована је имејл адреса на uk-koeln.de